A six week double-blind, randomized, multicenter comparison study of the analgesic effectiveness of celecoxib 200 mg bid compared to tramadol hydrochloride 50 mg qid in subjects with chronic low back pain.

Trial Profile

A six week double-blind, randomized, multicenter comparison study of the analgesic effectiveness of celecoxib 200 mg bid compared to tramadol hydrochloride 50 mg qid in subjects with chronic low back pain.

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Feb 2010

At a glance

  • Drugs Celecoxib; Tramadol
  • Indications Back pain
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 20 Oct 2009 Primary endpoint 'clinical response rate' has been met.
    • 20 Oct 2009 Results presented at the 73rd Annual Scientific Meeting of the American College of Rheumatology and the 44th Annual Meeting of the Association of Rheumatology Health Professionals.
    • 18 Nov 2008 Actual end date (Sep 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top